tag:blogger.com,1999:blog-21334986950418567562012-01-25T14:52:50.566-05:00Breast Imaging NewsMammography and related diagnostic breast imaging news, advances in breast imaging technology, and articles of interest to both health care professionals and patients.Radnoreply@blogger.comBlogger2851100tag:blogger.com,1999:blog-2133498695041856756.post-34372171390029379452012-01-25T14:52:00.000-05:002012-01-25T14:52:50.577-05:00First Naviscan PET Scanners Installed in EuropePositron Emission Mammography Now Available to Women in Germany and Turkey
SAN DIEGO, CA, Jan 25, 2012 (MARKETWIRE via COMTEX) -- Naviscan PET scanners performing Positron Emission Mammography (PEM) have been installed in two prestigious European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey. Capitalizing on Naviscan's distribution in 13 EuropeanRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-49962499090993084302012-01-14T12:10:00.000-05:002012-01-14T12:10:00.093-05:00Intrinsic Imaging Awarded Important Clinical Trial for the Evaluation of Breast CancerIntrinsic Imaging, an ISO 9001:2008 certified medical imaging core lab providing clinical image management and radiological review services in support of pharmaceutical, biotechnology, medical device and clinical research organizations, announces today that it was recently awarded an important clinical trial for the evaluation of breast cancer.
Over the duration of this clinical trial, IntrinsicRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-9016919074577991062011-12-16T09:47:00.000-05:002011-12-16T09:47:44.130-05:00Mammography Study in BMJ Flawed: Discredited Data UsedNewswise — Discredited and obsolete data used in Raftery and Chorozoglou, published Dec. 8 in the British Medical Journal, underestimated lives saved by mammography screening by half. The authors' comparison of inconvenience and anxiety of false positives to breast cancer deaths is also questionable.
“The estimated 15 percent reduction in breast cancer deaths used in this study is the same used Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-82238832367965096432011-12-11T19:52:00.001-05:002011-12-11T19:53:32.937-05:00Breast cancer patients face increasing number of imaging visits before surgerySAN ANTONIO, TX -- Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand a person's disease and determine the best course of action. In recent years, however, imaging has increased in dramatic and significant ways, say Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-51504828879178797232011-12-09T09:23:00.000-05:002011-12-09T09:23:15.834-05:00Breast-Mammogram Detector Mismatch Results in Excess RadiationBy: PATRICE WENDLING, Family Practice News Digital Network
CHICAGO – A mismatch between breast size and detector size during mammography resulted in significantly higher doses of radiation for women with large breasts in a study of 886 patients.
On average, women with large breasts screened on a small detector received almost 5 milligray (mGy) of radiation, which exceeds the American College of Radnoreply@blogger.com1tag:blogger.com,1999:blog-2133498695041856756.post-2016030436991480942011-12-05T14:21:00.000-05:002011-12-05T14:21:33.789-05:00New trials show land mine technology can give women fast, accurate breast cancer screeningDeveloped by Micrima, a spin-out from Bristol University, the revolutionary new screening technology – developed from a land mine detection project - now takes just eight seconds to provide a three-dimensional breast scan that provides results that are comparable with X-ray mammograms.
However, the MARIA (Multistatic Array processing for Radiowave Image Acquisition) system is not only safer and Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-61181349226544228032011-12-01T22:18:00.000-05:002011-12-01T22:18:13.903-05:00New Study Supports Mammography Screening at 40CHICAGO, Nov. 29, 2011 /PRNewswire/ -- Women in their 40s with no family history of breast cancer are just as likely to develop invasive breast cancer as are women with a family history of the disease, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). These findings indicate that women in this age group would benefit from annual Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-36198957397845845432011-12-01T11:41:00.000-05:002011-12-01T11:41:19.715-05:00BSGI/MBI Proven to Be Equivalent to MRI in the Detection of Breast CancerNEWPORT NEWS, Va., Nov. 30, 2011 /CHICAGOPRESSRELEASE.COM/ — Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), has been found to be equivalent to Magnetic Resonance Imaging (MRI) as an adjunct imaging modality in the diagnosis of breast cancer. BSGI/MBI may be especially useful for the evaluation of high-risk women or those with dense breasts. These findings willRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-67989296966330113982011-11-28T21:44:00.000-05:002011-11-28T21:44:04.489-05:00Hologic Introduces Synthesized 2D Image Algorithm Designed to Eliminate the Need for a 2D Mammogram in a 2D plus 3D Tomosynthesis ExamBEDFORD, Mass., November 27, 2011 /PRNewswire/ - Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the commercial release of its C-View synthesized 2D image reconstruction algorithm that eliminates theRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-65818016479244779312011-11-25T21:56:00.000-05:002011-11-25T21:56:03.795-05:00CoActiv Medical and PenRad Announce Sales Alliance to Provide Integrated Mammography Image and Information ManagementRIDGEFIELD, Conn.--(BUSINESS WIRE)--CoActiv Medical announces a sales alliance with PenRad for the delivery of an advanced, integrated image and information management solution for mammography. The new relationship will enable both companies to deliver a seamlessly integrated solution combining CoActiv EXAM-PACS® and CoActiv EXAM-VAULT® Archiving with the complete suite of PenRad Mammography Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-73883331339928028102011-10-31T18:06:00.001-04:002011-10-31T18:07:06.692-04:00U-Systems Hosts Second "Innovators in Breast Ultrasound Screening" Webcast Focusing on New Approaches to Breast Cancer ScreeningSUNNYVALE, Calif., Oct 28, 2011 (BUSINESS WIRE) -- U-Systems, the leader in automated breast ultrasound (ABUS) technology, today announced another in their series of "Innovators in Breast Ultrasound Screening," webcasts, focusing on progressive approaches to breast cancer screening. The live interactive web-broadcast is scheduled for Tuesday, November 1st at 5pm PST (8pm EST). Registration Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-74466766316860002792011-05-15T16:32:00.002-04:002011-05-15T16:32:42.226-04:00Latest Clinical Evidence Supports Promising Outlook For Low-Dose Molecular Breast Imaging (MBI)The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in Pittsburgh, Pa., shared preliminary results from a prospective study on low-dose MBI, specifically Breast-Specific Gamma Imaging (BSGI), at the SNMRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-76729854288049815072011-03-22T21:18:00.000-04:002011-03-22T21:18:58.281-04:00Matakina and PenRad Sign Letter of Intent to Display Volpara™ Volumetric Breast Density Results on Mammography Review StationFor Use with Digital Mammography, Volpara is Designed to Assist Radiologists by Objectively and Automatically Assessing a Women's Breast Tissue Density
LAS VEGAS, March 15, 2011 /PRNewswire/ -- Matakina International, Limited of New Zealand and PenRad Technologies, Inc., a leader in medical image and information management, today announced that the companies have signed a Letter of Intent (LOI) Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-32147460706170432572011-03-21T15:27:00.000-04:002011-03-21T15:27:42.594-04:00New Technologies Open the Door for Low Dose Breast-Specific Gamma Imaging (BSGI) / Molecular Breast Imaging (MBI)LAS VEGAS, March 17, 2011 /PRNewswire/ -- A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation doseRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-23705292792889352672011-03-15T10:27:00.000-04:002011-03-15T10:27:31.126-04:00For Use with Digital Mammography, Volpara is Designed to Assist Radiologists by Objectively and Automatically Assessing a Women's Breast Tissue DensityLAS VEGAS, March 15, 2011 /PRNewswire/ -- Matakina International, Limited of New Zealand and PenRad Technologies, Inc., a leader in medical image and information management, today announced that the companies have signed a Letter of Intent (LOI) to use the PenRad Mammography Information System (MIS) to display the Volpara™ breast imaging software. The announcement was made from the National Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-75492957155731956142011-03-12T19:15:00.000-05:002011-03-12T19:15:53.408-05:00Naviscan Announces European Launch of Positron Emission MammographyVIENNA, March 2, 2011 /PRNewswire/ -- Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography (PEM) scanner at two prestigious radiology conferences in Vienna. On March 3rd, at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, a podium presentation will focus on recently published PEM (Positron Emission Mammography) data demonstrating Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-24570929324373140752011-03-07T22:02:00.000-05:002011-03-07T22:02:08.470-05:00SuperSonic Imagine Reports Validation of Clinical Benefits of ShearWave™ ElastographyMarch 5th, 2011 (Aix-en-Provence, France). SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.
Launched by SuperSonic Imagine in June 2008, the global, multi-centre study was conducted across 16 American and European Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-46267764233951765392011-03-02T09:34:00.000-05:002011-03-02T09:34:12.603-05:00Naviscan Announces European Launch of Positron Emission MammographyEuropean Launch Marked By Presentations of Significant New Clinical Data Demonstrating the Value of PEM in Improving Treatment Decisions for Breast Cancer
VIENNA, March 2, 2011 /PRNewswire/ -- Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography (PEM) scanner at two prestigious radiology conferences in Vienna. On March 3rd, at the European Society of Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-41210641641683785832011-03-01T19:13:00.001-05:002011-03-01T19:14:27.852-05:00Comprehensive Guide Offers Multiple Radiologic Modalities in Breast Imaging(openPR) - New York/Stuttgart – Recently published by Thieme, Diagnosis of Breast Diseases: Integrating the Findings of Clinical Presentation, Mammography, and Ultrasoundoffers key information on the diagnosis of breast diseases using the clinical examination and various radiological modalities. With more than 1,500 radiographs, ultrasound images, and mammograms, this lavishly illustrated atlas Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-87639198712111199142011-02-24T18:13:00.000-05:002011-02-24T18:13:49.929-05:00TechniScan signs agreement with Texas-based company to co-develop a new version of its breast imaging deviceSALT LAKE CITY (January 18, 2011) – TechniScan (OTCBB: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced today that it has signed a Product Development Agreement with Austin, Texas based Womens3D, Inc. worth a minimum of $1.5 million.
TechniScan and Womens3D will co-develop technology specifically for Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-4255949989654569222011-02-21T14:36:00.000-05:002011-02-21T14:36:45.808-05:00Breast cancer screening with MRI benefits women with radiation therapy historyOAK BROOK, Ill. – Breast cancer screening with MRI can detect invasive cancers missed on mammography in women who've undergone chest irradiation for other diseases, according to a new study published online and in the April print edition of Radiology.
Women who receive radiation therapy as children and young adults for diseases like Hodgkin's lymphoma face a significantly greater risk of breast Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-49634870363745802522011-02-18T14:56:00.000-05:002011-02-18T14:56:34.138-05:00Siemens Celebrates First US Installation of MAMMOMAT Inspiration Full-Field Digital Mammography SystemMalvern, Pa., February 15, 2011 – Siemens introduces its next generation of digital mammography with the first US installation of its MAMMOMAT® Inspiration at one of Zwanger-Pesiri Radiology’s nine locations on Long Island, New York. The Inspiration offers digital screening and diagnostic mammography, stereotactic biopsy, and upgrade capability to future technologies all in one system.
“The Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-8876174616934237012011-02-11T18:13:00.000-05:002011-02-11T18:13:36.350-05:00Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) SystemBEDFORD, Mass., Feb. 11, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company received approval from the U.S. Food and Drug Administration (FDA) for its Selenia DimensionsRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-90148325356327908302011-02-09T17:27:00.000-05:002011-02-09T17:27:22.602-05:00Hologic Targets Women's Health Professionals at ECR 2011BEDFORD, Mass., Feb. 8, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on new, ready to market technologies in women's imaging at the European Congress of Radiology (ECR), the Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-66289463355504323702011-01-18T11:07:00.000-05:002011-01-18T11:07:50.579-05:00Siemens to Give Away a MAMMOMAT Inspiration in “Who Inspires You?” Video ContestMalvern, Pa., Jan. 6, 2011– In celebration of the launch of the MAMMOMAT® Inspiration, Siemens new full-field digital mammography system, the company announces the “Who Inspires You?” contest. The winning hospital or imaging center will receive a brand new MAMMOMAT Inspiration and five runners-up will receive a $10,000 voucher toward the purchase of a new Inspiration.
“Siemens conducted customerRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-25793446893325343642011-01-04T18:27:00.000-05:002011-01-04T18:27:31.241-05:00Preoperative Breast MRI Suggests High Cancer Yield and Positive Predictive Value in Newly Diagnosed Patients, Study FindsThe use of preoperative Breast MRI detects otherwise occult cancer with a relatively high degree of accuracy when applied to a diverse population of patients newly diagnosed with breast cancer, according to a study in the January issue of the American Journal of Roentgenology.
The study was performed at the University of Washington and Seattle Cancer Care Alliance in Seattle, WA. The review Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-88424388520308020792010-12-20T21:59:00.000-05:002010-12-20T21:59:07.373-05:00Carestream Health Announces FDA Approval Of Advanced Software, Screens For Its CR Mammography SystemROCHESTER, N.Y., Dec. 9 — Carestream Health announced the U.S. Food and Drug Administration (FDA) has approved a Premarket Approval (PMA) supplement for enhanced screens and image processing software for its CR mammography system.
Carestream Health’s EHR-M3 screens are its third generation of screens designed specifically for mammography. The system has higher DQE (detective quantum efficiency)Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-6272899025539941462010-12-18T21:33:00.000-05:002010-12-18T21:33:56.826-05:00Advances in Breast Imaging Improve Patient Care, Aid in Earlier Cancer DetectionOREM, UT, December 16, 2010 /24-7PressRelease/ -- The new KLAS "Breast Imaging 2010: A More Complete Picture" report takes an all-inclusive look at breast imaging technologies from a patient perspective, beginning with digital mammography and moving through CAD, MIS and ending with a discussion of newer breast-specific imaging technologies. Providers were noticeably energized about Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-92103846257833161152010-12-13T11:24:00.000-05:002010-12-13T11:24:52.948-05:00Novel Imaging Technique May Reduce Lymphedema in Breast Cancer PatientsSAN ANTONIO — With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.
The researchers report that integrating single photon emission computed tomography(SPECT) with the computerized tomography(CT) scans utilized for breast cancer Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-85310263098711285552010-12-04T12:44:00.001-05:002010-12-04T12:45:31.687-05:00Toshiba Enhances Aplio XG with Women’s Imaging Configuration Designed to Improve Breast and High-Risk OB/GYN ImagingCHICAGO, Dec. 1, 2010 – Many healthcare providers use ultrasound as a first-line diagnostic tool in detecting and monitoring women’s health conditions. To help meet the needs of healthcare providers administering women’s imaging, Toshiba has introduced a women’s imaging configuration for the AplioTM XG at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 28 Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-84995913701597203792010-11-29T21:31:00.001-05:002010-11-29T21:33:34.583-05:00U-Systems Introduces Significant Upgrades to 3D Automated Breast Ultrasound Workstation at RSNACHICAGO, Nov 29, 2010 (BUSINESS WIRE) -- U-Systems, Inc., the leader in automated breast ultrasound, announced significant upgrades for its somo*v(R) Automated Breast Ultrasound System (ABUS) at the 96th Annual Meeting of the Radiology Society of North America, November 28 -- December 3. Featuring software improvements and hardware-accelerated programming, Release One*5 and SomoSTORAGE(TM) Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-11852916125756509012010-11-26T13:34:00.000-05:002010-11-26T13:35:44.928-05:00Hologic Receives FDA Approvable Letter For Selenia Dimensions (3-D) Digital Mammography Tomosynthesis SystemBEDFORD, Mass., (November 23, 2010) - Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that Hologic has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Selenia Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-9360659714916383112010-11-19T17:19:00.000-05:002010-11-19T17:20:51.535-05:00Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S.Malvern, Pa., November 17, 2010 – Siemens announces that the MAMMOMAT® Inspiration Full-Field Digital Mammography System is now commercially available in the United States. The MAMMOMAT Inspiration offers digital screening and diagnostic mammography, stereotactic biopsy, and upgrade capability to future technologies all in one system.Siemens conducted customer workshops around the world, in whichRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-62612528959306915422010-11-17T21:45:00.000-05:002010-11-17T21:46:19.485-05:00Radiology Journal Publishes Data That PEM Scanners May Reduce Unnecessary Breast Biopsies And Offer An Alternative For Women Who Cannot Tolerate MRIThe Radiology journal released new data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer that shows Positron Emission Mammography (PEM) may reduce unnecessary breast biopsies. The study found that PEM was significantly more precise at identifying benign and cancerous lesions, in what scientists call "Positive Predictive Value" or "PPV," therefore Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-28261886646902881802010-11-05T18:16:00.000-04:002010-11-05T18:17:29.776-04:00FDA Reclassifies Certain Digital Mammography DevicesThe U.S. Food and Drug Administration announced that it is easing the pathway to market for mammography systems that produce computerized X-ray images of the entire breast.These systems, known as Full Field Digital Mammography Systems, are an alternative to mammography systems that produce X-ray film.When first approved by FDA in 2000, digital mammography systems were categorized as a high risk Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-35125852288079014072010-10-15T22:12:00.000-04:002010-10-15T22:14:04.900-04:00Study Determines Breast-Specific Gamma Imaging Is More Effective Than Ultrasound in Patients With Complex Breast TissueWASHINGTON, Oct. 6 /PRNewswire/ -- Results of a study on Breast-Specific Gamma Imaging (BSGI) presented at the annual breast meeting of the American Society of Clinical Oncology in Washington, D.C., showed that BSGI was nearly twice as effective in finding cancers and more than three times as likely to lead to the correct diagnosis when compared to ultrasound.Breast-specific gamma imaging (BSGI) Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-31059590064366390372010-08-30T18:42:00.001-04:002010-08-30T18:43:54.816-04:00Preliminary Research Results Suggest Up To 70% Reduction In Dose For Positron Emission Mammography ImagingIn a recent study presented at the American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting, researchers at the University of Washington showed that 18FDG dose for Positron Emission Mammography (PEM) may be reduced by as much as 70% without altering image quality.PEM scanners are high-resolution breast PET systems that show the location as well as the metabolic phase of a lesion.Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-20476971576385014742010-08-05T22:29:00.000-04:002010-08-05T22:30:43.969-04:00Hologic Completes Acquisition of Sentinelle MedicalBEDFORD, Mass., Aug 05, 2010 /PRNewswire via COMTEX/ -- Hologic, Inc. (Hologic or the Company) /quotes/comstock/15*!holx/quotes/nls/holx (HOLX 15.90, -0.16, -0.10%) , a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the completion of its acquisition of Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-64347006537339477892010-07-07T14:29:00.000-04:002010-07-07T14:30:15.911-04:00Hologic to Acquire Sentinelle MedicalBEDFORD, Mass., July 6 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has entered into a definitive agreement to acquire Sentinelle Medical Inc. (Sentinelle Medical), a Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-8586693930399608412010-06-17T10:33:00.000-04:002010-06-17T10:34:31.326-04:00TechniScan announces adding another center to worldwide clinical trials for new breast imaging systemSALT LAKE CITY (June 16, 2010) – TechniScan, (OTC BB: TSNI) a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, today announced that it has launched a clinical study in Rochester, Minn., its third new clinical site to commence in the last five months.TechniScan’s Warm Bath Ultrasound (WBU) system is designed to capture Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-44623329431572843602010-06-07T10:55:00.000-04:002010-06-07T11:18:10.093-04:00GE Healthcare Collaborates on Investigational Molecular Breast Imaging System for Early Breast Cancer DetectionGE Healthcare, a unit of General Electric Company (NYSE: GE), announced its collaboration in two clinical trials with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and Hamilton Health Sciences Hospital in Ontario, Canada on the use of a novel technology that may assist in assessment and early detection of breast cancer in women who are at high risk for the disease.GE Healthcare’s Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-89241768339211285272010-06-01T12:31:00.000-04:002010-06-01T12:32:32.875-04:00GE Healthcare Unveils Innovative Technology in Breast Cancer Imaging; Can Reduce Time from Detection to DiagnosisPARIS, Jun 01, 2010 (BUSINESS WIRE) -- GE Healthcare /quotes/comstock/13*!ge/quotes/nls/ge (GE 16.32, -0.03, -0.18%) , a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright(1) Contrast Enhanced Spectral Mammography (CESM) technology reduces ambiguity in mammography results, enabling Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-68725254915835613252010-05-23T22:23:00.000-04:002010-05-23T22:24:33.919-04:00Patent Awarded to the Design of TechniScan's Unique 3-D Breast Imaging SystemSALT LAKE CITY, May 13 /PRNewswire-FirstCall/ -- A newly awarded U.S. Patent will protect TechniScan, Inc's., (OTC Bulletin Board: TSNI) novel way to image, biopsy and treat breast cancer.U.S. Patent 7,699,783 B2 titled "Method for Imaging and Treating a Breast" covers the company's design of a 3-D, Warm Bath Ultrasound™ system that images while a woman lies prone on a table with her breast Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-58289285807718948992010-05-17T15:08:00.000-04:002010-05-17T15:10:01.294-04:00New Concerns About Radiation And Breast CancerIt is well established that exposure to ionizing radiation can result in mutations or other genetic damage that cause cells to turn cancerous. Now a new study led by researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) has revealed another way in which radiation can promote cancer development. Working with cultures of human breast cells, the Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-48242767097781705172010-05-03T22:04:00.000-04:002010-05-03T22:05:16.358-04:00Breast MRI Could Reduce Local Breast Cancer Recurrence Rates, Study SuggestsThe use of preoperative breast magnetic resonance imaging (MRI) prior to surgical intervention (for the treatment of breast cancer) can reduce the number of local (confined to the breast) cancer recurrences at follow-up, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. MRI of the breast is a noninvasive medical test that helps physicians diagnose and treat Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-18696961716428166612010-05-02T08:54:00.000-04:002010-05-02T08:56:08.890-04:00BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant ChemotherapyNEWPORT NEWS, Va., April 30 /PRNewswire/ -- A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy. BSGI, a molecular breast imaging technique (MBI), has been proven in several other studies to improve breast cancer Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-54785349446426398992010-04-23T13:22:00.001-04:002010-04-23T13:24:35.858-04:00Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than MammogramALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCBB: MHTX) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.When fully developed and commercialized, Dr. Flynn's Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-52197301178237192872010-04-21T16:42:00.000-04:002010-04-21T16:43:52.388-04:00Montgomery Breast Center First To Install Breast Cancer Lesion-Localization SystemThe Montgomery Breast Center of Montgomery, Ala., is the first center in the country to install and use the GammaLoc® lesion-localization system. This system is the only FDA-cleared device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with Breast-Specific Gamma Imaging (BSGI). BSGI is performed by the Dilon 6800®, a gamma camera that is optimized to Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-42241093874709817242010-04-19T07:26:00.000-04:002010-04-19T07:27:55.096-04:00Innovation in Mathematics Leads to Revolutionary Breast Imaging SystemTechniScan's scientific breakthrough in Inverse Scattering presented to doctors and scientists at AIUM conferenceSALT LAKE CITY, April 7 /PRNewswire-FirstCall/ -- The groundbreaking algorithms developed at TechniScan, Inc. (OTC Bulletin Board: TSNI) have led to a new arena of whole breast ultrasound technology, as presented at a national medical ultrasound conference in San Diego in Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-89953794253486840642010-04-02T15:25:00.000-04:002010-04-02T15:27:42.873-04:00Pioneering Breast Scanner Holds Great Promise for Accurately Detecting and Diagnosing Breast Cancer at Its Earliest StagesCHARLOTTESVILLE, Va., April 1, 2010 - Perhaps no one can appreciate the importance of early cancer detection as much as Izora Armstrong. That's because UVA Cancer Center researchers, using a first-of-its-kind hybrid breast imaging device, found what mammography, ultrasound, MRI and even a needle biopsy couldn't."I feel truly blessed that I came to UVA, that they gave me the chance to be a part Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-23140448739804545022010-03-27T10:45:00.000-04:002010-03-27T10:49:07.481-04:00Study questions whether screening really cuts breast cancer deathsA study from Denmark published on bmj.com today finds no effect of the Danish screening programme on breast cancer deaths.Similar results have been seen in other countries, including the UK, leading the authors to question whether screening has delivered the promised effect on breast cancer mortality.A 2005 study suggested that screening had reduced breast cancer deaths by 25% in Copenhagen. But Radnoreply@blogger.com2tag:blogger.com,1999:blog-2133498695041856756.post-49132226318965602932010-03-20T15:50:00.001-04:002010-03-20T15:52:05.056-04:00Intelerad to Showcase IntelePACS Breast Imaging at the 20th Annual National Interdisciplinary Breast Center ConferenceIntelerad Medical Systems will be demonstrating the new IntelePACS® Breast Imaging fully-integrated, multi-modality mammography solution at the 20th Annual National Interdisciplinary Breast Center Conference.IntelePACS Breast Imaging provides radiologists with instant access to a universal multi-modality worklist that drives the workflow and viewing process, answering the specific needs of Radnoreply@blogger.com1tag:blogger.com,1999:blog-2133498695041856756.post-74243821384444630092010-03-15T11:26:00.002-04:002010-03-15T11:33:03.215-04:00PEM scanners may reduce unnecessary breast biopsies and offer an alternative for women who cannot tolerate MRI.SAN DIEGO, CA – March 15, 2010 – New data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer shows that Positron Emission Mammography (PEM) may reduce unnecessarybreast biopsies. The study found that PEM was significantly more precise at identifying benign and cancerous lesions, in what scientists call “Positive Predictive Value” or “PPV,” therefore Radnoreply@blogger.com1tag:blogger.com,1999:blog-2133498695041856756.post-50659305138053170262010-03-09T14:50:00.000-05:002010-03-09T14:51:17.109-05:00MRI Finds Tumors In Second Breast Of Women Diagnosed With Cancer In One BreastPostmenopausal women, including those over 70 years old, who have been newly diagnosed with cancer in one breast have higher cancer detection rates when the other breast is scanned for tumors with MRI, compared to premenopausal women, say researchers at the Mayo Clinic campus in Florida.They found that 3.8 percent of 425 women had breast cancer in the undiagnosed breast that had not been found Radnoreply@blogger.com1tag:blogger.com,1999:blog-2133498695041856756.post-52629828926613602802010-02-23T11:59:00.001-05:002010-02-23T12:01:12.454-05:00ACR, SBI: Avon Survey Reveals Potentially Deadly Effects of USPSTF Mammography RecommendationsA recent Avon Foundation for Women survey confirms what the American College of Radiology and other experts warned would happen: states are using deeply flawed and widely discredited U.S. Preventative Services Task Force mammography recommendations to deny women coverage for mammograms, and many women are foregoing long proven, life-saving mammography care based on the mistaken USPSTF Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-45655281688098587352010-02-22T10:23:00.000-05:002010-02-22T10:25:45.449-05:00New Ultrasound Breast Scanner Takes Up Operation In EuropeThe first models of the new Siemens ultrasound system Acuson S2000 Automated Breast Volume Scanner (ABVS) have taken up operation in European radiological and gynecological clinics and offices. Patients in Switzerland, France, Portugal, Norway and Germany can now be examined with the new system. Thanks to its more accurate, three-dimensional image acquisition, the technology is particularly Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-42111888406061109432010-02-16T15:48:00.000-05:002010-02-16T15:49:32.483-05:00Preoperative MRI Deemed Unnecessary in Women with Early-stage Breast CancerResearchers from the UK affiliated with the COMICE randomized trial have reported that preoperative magnetic resonance imaging (MRI) does not affect reoperation rates in women with early-stage breast cancer. The details of this study appeared in the February 13, 2010 issue of the Lancet.[1]Preoperative MRI is increasingly being used in women with early-stage breast cancer who are undergoing Radnoreply@blogger.com1tag:blogger.com,1999:blog-2133498695041856756.post-73201573299432161482010-01-23T14:01:00.000-05:002010-01-23T14:02:43.308-05:00Digital Mammography Delivers Significantly Less Radiation than Conventional MammographyData from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-62284897821203300792010-01-05T09:28:00.000-05:002010-01-05T09:29:49.281-05:00Breast Cancer Screening Should Begin at Age 40, New Recommendations SuggestScienceDaily (Jan. 5, 2010) — The new recommendations from the Society of Breast Imaging (SBI) and the American College of Radiology (ACR) on breast cancer screening, published in the January issue of the Journal of the American College of Radiology (JACR), state that breast cancer screening should begin at age 40 and earlier in high-risk patients. The recommendations also suggest appropriate Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-3049072935359879462010-01-04T15:35:00.000-05:002010-01-04T15:37:31.024-05:00Baylor Adds Naviscan PEM Technology to Women’s Imaging CenterThe Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women’s Imaging Center. Baylor will use PEM (positron emission mammography) to complement their existing anatomical tools by providing a three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians to make cancer care decisions by providing an Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-61357203231019744662009-12-29T19:08:00.000-05:002009-12-29T19:09:58.118-05:00Baylor Adds Naviscan PEM Technology to Women's Imaging CenterSAN DIEGO, Dec. 22 /PRNewswire/ -- The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM scanner at its Darlene G. Cass Women's Imaging Center. Baylor will utilize PEM (Positron Emission Mammography) to complement their existing anatomical tools by providing a critical three-dimensional metabolic perspective of breast cancer. The metabolic view allows physicians toRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-81588356525382648742009-12-24T11:34:00.000-05:002009-12-24T11:36:02.210-05:00How Do You Improve Mammogram Accuracy? Add NoiseMembers of a Syracuse University research team have shown that an obscure phenomenon called stochastic resonance (SR) can improve the clarity of signals in systems such as radar, sonar and even radiography, used in medical clinics to detect signs of breast cancer. It does this by adding carefully selected noise to the system.The result has been a distinct improvement in the system's ability to Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-53990006851177265702009-12-22T15:24:00.000-05:002009-12-22T15:26:08.458-05:00Elevated-Risk Women Refuse MRI Breast Cancer ScreeningScienceDaily (Dec. 22, 2009) — In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure."Given that MRI is promoted as a very sensitive test to identify early breast cancer, we were surprised that barely half of women at increased risk for breast cancer would undergo MRI even when offered at no Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-76132997170424668952009-12-21T09:31:00.000-05:002009-12-21T09:32:32.222-05:00Dilon Diagnostics Gamma-Guided Localization System Cleared by FDAGammaLoc(R) Helps Locate Breast Lesions Quickly and Accurately for BiopsyNEWPORT NEWS, Va., Dec. 21 /PRNewswire/ -- Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.GammaLoc(®), pronounced "gamma-loke", is a complementary technology to Dilon's cornerstone productRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-17908605746437481302009-12-08T09:52:00.000-05:002009-12-08T09:54:17.263-05:00Mammography Use and False Positives Among Women Younger Than 40 Years Old Differ Between Minority PopulationsHOUSTON - Breast cancer screening guidelines generally recommend mammography begin at age 40. However, based on prior national research, an estimated 34 percent of non-Hispanic black women, 30 percent of non-Hispanic white women and 22 percent of Hispanic women aged 30 to 39 have reported having a mammogram."Our goals are to better understand who these women are that are getting mammograms at Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-36621277692595797872009-12-06T16:27:00.000-05:002009-12-06T16:28:14.233-05:00New FDA Approved Breast Cancer Screening ToolSCOTTSDALE, Ariz., Dec. 6 /PRNewswire/ -- The FDA has approved new technology that now allows radiologists to detect breast cancer sooner and faster. The SonoCine Automated Whole-breast Ultrasound Method and is being offered by only one facility in Arizona - Arizona Breastnet, in Scottsdale. This unique technology is designed specifically as a breast cancer screening tool to enhance yearly Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-20249393137074872232009-12-02T12:57:00.000-05:002009-12-02T12:59:26.771-05:00Philips Introduces Multi-modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast CareChicago, USA – At this year’s annual meeting of the Radiological Society of North America (RSNA), Royal Philips Electronics (NYSE: PHG, AEX: PHI) will introduce the Integral Breast Workspace, a set of solutions that provides radiologists the ability to review multi-modality breast images at one workspot to help drive quality and efficiency. Showcasing its commitment to breast care, Philips will Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-74261102463692270172009-11-30T07:22:00.000-05:002009-11-30T07:24:08.480-05:00Elastography Reduces Unnecessary Breast BiopsiesElastography is an effective, convenient technique that, when added to breast ultrasound, helps distinguish cancerous breast lesions from benign results, according to an ongoing study presented at the annual meeting of the Radiological Society of North America (RSNA).When mammography yields suspicious findings, physicians often use ultrasound to obtain additional information. However, ultrasound Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-71590946566768551862009-11-23T14:34:00.000-05:002009-11-23T14:35:14.719-05:00Short-Term Follow-Up: A Reasonable Alternative to Immediate Biopsy of Palpable Breast Lesions With Benign Imaging FeaturesShort-term follow-up is a reasonable alternative to invasive biopsy of palpable (capable of being touched or felt) breast lesions with benign imaging features, particularly in younger women with probable fibroadenoma (non-cancerous tumors that often occur in women during their reproductive years), according to a study published in the December issue of the American Journal of Roentgenology.The Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-86333703190502867832009-11-20T09:15:00.000-05:002009-11-20T09:16:01.290-05:00Esteemed Endorsements Recognize Promising Future Of Breast-Specific Gamma Imaging (BSGI)Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) has been recognized and endorsed by two highly esteemed organizations for the fight against breast cancer: The Society of Breast Imaging (SBI) and the American College of Surgeons. Both societies published articles supporting the further application of this breakthrough imaging technology for the early detection of breast cancer."Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-38419995487091266002009-11-19T18:05:00.000-05:002009-11-19T18:07:02.820-05:00AMICAS PACS For Mammography at RSNA 2009BOSTON, Nov. 12 /PRNewswire-FirstCall/ -- AMICAS, Inc. (NASDAQ: AMCS), a leader in image and information management solutions, today announced that it will showcase the intrinsic mammography capabilities of AMICAS PACS™ at the 2009 Radiological Society of North America (RSNA) annual meeting from November 29 to December 4 in Chicago, IL. AMICAS will be in the North Hall in booth #7124.AMICAS PACS Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-61069105637094467732009-11-18T06:47:00.001-05:002009-11-18T07:03:17.876-05:00USPSTF Mammography Recommendations Will Result In Countless Unnecessary Breast Cancer Deaths Each YearIf cost-cutting U.S. Preventive Services Task Force (USPSTF) mammography recommendations are adopted as policy, two decades of decline in breast cancer mortality could be reversed and countless American women may die needlessly from breast cancer each year. The recommendations - created by a federal government-funded committee with no medical imaging representation - would advise against regular Radnoreply@blogger.com2tag:blogger.com,1999:blog-2133498695041856756.post-31574075729640714812009-11-17T18:25:00.000-05:002009-11-17T18:26:59.143-05:00Karmanos Cancer Institute Launches Company and Innovative Breast Imaging ToolDETROIT, Nov. 16 /PRNewswire-USNewswire/ -- After more than 10 years of research and development, the Barbara Ann Karmanos Cancer Institute announced its launch of a new company to build and market a breast cancer screening device invented at Karmanos. The innovative technology developed as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as SoftVue, will be marketed under the Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-38945289750207674932009-11-16T19:59:00.002-05:002009-11-16T20:03:50.103-05:00Less is more in new breast-cancer screening recommendationsThe long-standing recommendation that women age 40 and older at average risk of breast cancer get annual mammograms and the notion that women benefit from doing breast self-examination at home is being turned on its head. In a nod to the risks of false positives and unnecessary procedures that mammograms can generate, especially in younger women, the U.S. Preventive Services Task Force issued newRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-19562423333033987212009-11-13T21:48:00.001-05:002009-11-13T21:49:46.893-05:00AMICAS PACS For Mammography at RSNA 2009BOSTON, Nov. 12 /PRNewswire-FirstCall/ -- AMICAS, Inc. (NASDAQ: AMCS), a leader in image and information management solutions, today announced that it will showcase the intrinsic mammography capabilities of AMICAS PACS™ at the 2009 Radiological Society of North America (RSNA) annual meeting from November 29 to December 4 in Chicago, IL. AMICAS will be in the North Hall in booth #7124.AMICAS PACS Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-80898279088775377992009-11-09T09:05:00.000-05:002009-11-09T09:06:43.444-05:00Study Finds Higher Risk Of Cancer Recurrence In Women With Dense BreastsA new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation.Previous studies Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-65716218821281651682009-11-01T10:19:00.002-05:002009-11-01T10:23:20.145-05:00High-Resolution Breast PET Improves Breast Cancer DetectionAn NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions. The prospective study also found that the combination of PEM and breast MRI dramatically increases a physician's ability to detect potentially cancerous lesions over MRI Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-17827780567910832872009-10-30T13:32:00.000-04:002009-10-30T13:34:16.572-04:00New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast TumorsResearchers at Thomas Jefferson University in Philadelphia, PA, supported in part by NuView Life Sciences, have published an article in the Journal of Nuclear Medicine reporting preclinical results of a novel PET biomarker designed to selectively detect malignant breast tumors[1]. "All tumors detected with the new biomarker were malignant and expressed the targeted VPAC1 receptors located on the Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-8629260541136124412009-10-09T14:34:00.001-04:002009-10-09T14:36:11.810-04:00Breast-Specific Gamma Imaging Proves Cost-Effective For Pre-Surgical Planning Of Patients With Known Cancer DiagnosisBreast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique with comparable sensitivity to breast magnetic resonance imaging (MRI) for detecting breast carcinoma when used in pre-surgical planning for patients with known cancer diagnoses and is substantially less expensive than MRI, according to findings presented at the American Society of Clinical Oncology Breast Cancer SymposiumRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-54910857900684682342009-10-08T19:20:00.000-04:002009-10-08T19:21:39.335-04:00Diffuse Optical Tomography For Breast Cancer Screening Fine-Tuned By ResearchersClemson University researchers in collaboration with researchers at the University of Bremen, Germany, are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home setting.The group is fine-tuning Diffuse Optical Tomography (DOT) to create high-resolution images from a scattering of infrared and Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-83293943441353039852009-10-07T16:43:00.000-04:002009-10-07T16:45:01.196-04:00Studies Advance Early Detection, Evaluation and Treatment of Breast CancerSAN FRANCISCO – New studies on the early detection, evaluation and treatment of breast cancer were released today in advance of the 2009 Breast Cancer Symposium. The symposium is being held October 8-10, 2009, at the San Francisco Marriott.Four major studies were highlighted today in a presscast (press briefing via live webcast): * Majority of breast cancer deaths occur among women who don’t Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-41963037158056057132009-09-30T18:20:00.000-04:002009-09-30T18:21:42.790-04:00Digital mammography: A decade battling breast cancerIn addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers. To commemorate the anniversary and its long-standing commitment to fighting breastRadnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-38846763434520111212009-09-10T13:28:00.002-04:002009-09-10T13:34:58.036-04:00Canadian Breast Imaging System Ushers in New Era of Breast Cancer ManagementCALGARY, Sept. 8 /CNW/ - Ontario biomedical engineer Cameron Piron is to receive a $25,000 prize from the Ernest C. Manning Awards Foundation for his development of a dedicated system for breast magnetic resonance imaging (MRI) and intervention.MRI is a safe and sensitive imaging tool, but it can be challenging to obtain high quality images of breast tissue. Piron's systemincorporates several Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-90098469774623985972009-09-01T14:05:00.000-04:002009-09-01T14:09:09.660-04:00Swift And Accurate Breast Biopsies Via Full-Field Digital MammographyPatients of the Mammography Department at NHS Fife's Queen Margaret Hospital are now benefitting from faster treatment due to the installation of a Full-Field Direct Digital Mammography system from Siemens Healthcare. The MAMMOMAT Inspiration™ includes a stereotactic biopsy attachment and syngo® MammoReport workstation.The stereotactic biopsy attachment provides the clinician with valuable Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-66293358697097926252009-08-05T15:44:00.000-04:002009-08-05T15:45:49.071-04:00Digital Mammography Plus Digital Breast Tomosynthesis May Decrease Patient Recall RatesNationally, about ten percent of women in the US are recalled for a second mammogram after an abnormality is detected on the first one—for most women this can be very stressful. However the use of digital breast tomosynthesis and full-field digital mammography combined may be associated with a substantial decrease in recall rate, according to a study performed at UPMC in Pittsburgh, PA. Some Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-69486387412560584982009-07-23T17:29:00.000-04:002009-07-23T17:31:15.624-04:00Enhanced Digital Breast Imaging From US Navy-Funded TechnologyA breakthrough technology adapted for breast cancer detection based in part on research originally sponsored by the Office of Naval Research (ONR) is set to air July 23 during a CNN International news segment on Vital Signs, a program hosted by Dr. Sanjay Gupta.The technology, referred to by the U.S. Navy as enhanced digital imaging, developed out of the Navy's need to improve capabilities to Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-88262156069106817252009-06-26T10:16:00.000-04:002009-06-26T10:17:03.441-04:00Study Challenges Routine Use Of MRI Scans To Evaluate Breast CancerReviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. The study demonstrates that, despite the lack of evidence of their benefit, routine use of MRI scans in women newly diagnosed Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-45934858588453092642009-06-23T21:20:00.000-04:002009-06-23T21:22:03.288-04:00SOMO·INSIGHT Clinical Study Detects First Cancer in Mammographically Negative Breast Screening Patient at OSF Saint Francis Medical CenterSAN JOSE, Calif. & PEORIA, Ill.--(BUSINESS WIRE)--U-Systems, the leader in dedicated breast ultrasound systems, together with Medical Director Jessica A. Guingrich, MD of OSF Saint Francis Medical Center, Susan G. Komen Breast Center and Centers for Breast Health announced that they have initiated the SOMO·INSIGHT Clinical Study. The first participants have been enrolled and the first Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-56772756352570526382009-06-17T16:42:00.000-04:002009-06-17T16:43:38.372-04:00FDA Clears Hologic R2™ DIGITALNOW™ HD Software ApplicationSoftware processes digitized prior film mammograms to produce DICOM images that more closely resemble digital mammogramsBEDFORD, Mass. (June 12, 2009) - Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-32064735625699279932009-06-15T11:54:00.000-04:002009-06-15T11:55:45.169-04:00Prototype Breast Cancer Imaging System May Improve Patient CareScienceDaily (June 15, 2009) — A prototype breast imaging system combining positron emission tomography (PET) and magnetic resonance imaging (MRI) technologies could greatly improve breast cancer imaging capabilities, according to researchers at SNM's 56th Annual Meeting. Although the system has not yet been tested on humans, initial results from the prototype indicate the system produces a Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-64295116155390767432009-06-11T18:20:00.000-04:002009-06-11T18:22:49.634-04:00Breast MRI shows it’s not the size of the lymph node that signals spread of cancerPhysicians treating breast cancer first look to lymph nodes in a patient’s armpit to see whether cancer is spreading elsewhere in the body — but they may not be evaluating the nodes in the most effective way.Initial research suggested that enlargement and abnormalities of axillary sentinel lymph nodes – located in the armpit area near the breast – were predictive of cancer. But a University of Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-34073177472577851092009-06-10T09:29:00.001-04:002009-06-10T09:34:06.825-04:00Siemens Mammomat Inspiration Wins Design AwardsMammomat Inspiration, the digital mammography platform designed by Siemens and designaffairs, has received the iF Product Design Award 2009 and the red dot award: product design 2009. The device for the early detection of breast cancer shows that ease of use, high functionality, and unique design come together beautifully in a single medical engineering product.Siemens Healthcare and Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-86950121127223446772009-06-03T09:46:00.000-04:002009-06-03T09:47:52.454-04:00External Beam Partial Breast Irradiation Most Cost-effective TreatmentExternal beam partial breast irradiation (EB-PBI) is the most cost-effective method for treating postmenopausal women with early-stage breast cancer based on utilities, recurrence risks and costs when compared to whole breast radiotherapy (WBRT) and brachytherapy partial breast irradiation (brachy-PBI), according to a study in the June 1 issue of the International Journal of Radiation Oncology*Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-1142254226743169332009-05-23T20:25:00.000-04:002009-05-23T20:27:29.610-04:00Breast MRI Detects Additional "Unsuspected" Cancers Not Seen On Mammography Or UltrasoundNearly 20% of patients with recently diagnosed breast cancer had additional malignant tumors found only by MRI, according to a study performed at Dartmouth Hitchcock Medical Center.A total of 199 patients with newly diagnosed breast cancer underwent breast MRI. "We found additional, unsuspected cancers in the ipsilateral breast (the one that had already been diagnosed with cancer) in 16% of Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-1549550741018872402009-05-18T18:57:00.000-04:002009-05-18T18:58:53.844-04:00Germany's Göttingen University Buys ART SoftScan Optical Breast Imaging SystemMontreal, Canada, May 12, 2009 - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that it has received a purchase order for one of its SoftScan® breast imaging systems from the Department of Radiology of the University Medical Center Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-55122822781770349952009-05-16T23:45:00.000-04:002009-05-16T23:46:17.637-04:00ARRS 2009: Diffusion-Weighted Imaging May Improve Accuracy of Breast MRIMay 4, 2009 (Boston, Massachusetts) — Diffusion-weighted imaging (DWI) used to distinguish malignant vs benign breast lesions during magnetic resonance imaging (MRI) is helpful and may reduce the number of unnecessary breast biopsies, according to new research.DWI is a technique involving the exchange of water molecules (diffusion) between breast tissue compartments. Diffusion rates vary between Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-57582501868300438332009-05-10T17:47:00.001-04:002009-05-10T17:49:24.656-04:003T MRI Detects “Early” Breast Cancer Not Seen on Mammography and Sonography3T MRI, a powerful tool for evaluating patients with a high risk of having breast cancer, can detect a significant number of lesions not found on mammography and sonography, according to a study performed at the University of Toledo Medical Center, Toledo, OH.The study included 434 women who underwent mammography, sonography and 3T MRI for the detection of malignant breast lesions—all women were Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-52527703451599639042009-05-04T15:14:00.000-04:002009-05-04T15:15:32.309-04:00Integrating PACS with Digital Mammography was Focus of Presentation at NCBC MeetingLAS VEGAS--(BUSINESS WIRE)--Integrating digital mammography with PACS proved far better than reading mammograms on mammo-only specialty workstations. That was the conclusion reported by a Pennsylvania hospital, in a poster presentation at the recent National Consortium of Breast Centers’ (NCBC) conference.The presentation was by Peggy Wright, Supervisor of Women’s Imaging at Butler Health System,Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-84192366186137986742009-04-30T10:54:00.000-04:002009-04-30T10:55:26.509-04:00Carestream Health’s Multi-Modality Breast Imaging Workstation Streamlines Digital Workflow, Improves Radiologist ProductivityROCHESTER, N.Y., April 23 — Healthcare facilities nationwide are turning to vendor-neutral, multi-modality breast imaging workstations to streamline reading of digital breast exams.“Productivity at many U.S. facilities is hampered by the need to read full-field digital mammography (FFDM) exams on each vendor’s proprietary workstation, and then switch to additional workstations to review other Radnoreply@blogger.com0tag:blogger.com,1999:blog-2133498695041856756.post-29171900383298229462009-04-27T19:21:00.000-04:002009-04-27T19:22:53.049-04:00Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical ManagementNEWPORT NEWS, Va., April 27 /PRNewswire/ -- A study from Beth Israel Medical Center, New York, revealed today that additional breast cancer was found in 9 percent of patients when Breast-Specific Gamma Imaging (BSGI) was used to complement mammography, substantially impacting surgical treatment. A total of 82 patients underwent BSGI for newly diagnosed breast cancer; of these, 18 had an Radnoreply@blogger.com0